SCHEMBL17038145

SCHEMBL17038145

COc1cc2sc(CBr)nc2cc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.43
RAB9A P51151 5/20 0.43
GAA P10253 2/20 0.43
MAPK1 P28482 1/20 0.43
ALOX15 P16050 1/20 0.40
ATM Q13315 1/20 0.40
STING1 Q86WV6 3/20 0.39
NQO2 P16083 4/20 0.39
MAPT P10636 5/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
PKM P14618 3/20 0.38
TSHR P16473 4/20 0.38
ALDH1A1 P00352 2/20 0.38
TP53 P04637 2/20 0.38
CYP3A4 P08684 1/20 0.38
LMNA P02545 2/20 0.36
POLB P06746 1/20 0.36
G6PD P11413 1/20 0.36
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15839223 0.89 STING1 (0.48) NPC1RAB9AGAAMAPK1ALOX15
SCHEMBL13735279 0.80 NQO2 (0.46) NPC1RAB9AGAAALOX15ATM
SCHEMBL15949819 0.79 STING1 (0.43) NPC1RAB9AGAAMAPK1ALOX15
SCHEMBL9310828 0.78 GAA (0.66) NPC1RAB9AGAAALOX15ATM
SCHEMBL11685051 0.76 CYP3A4 (0.68) NPC1RAB9AGAAALOX15ATM
SCHEMBL13164798 0.76 ALOX15 (0.43) NPC1RAB9AGAAALOX15ATM
SCHEMBL10271768 0.73 NPC1 (0.69) NPC1RAB9AGAAMAPK1ALOX15
SCHEMBL7542512 0.73 CYP1A2 (0.59) NPC1RAB9AGAAMAPTSMN1; SMN2
SCHEMBL30917348 0.73 NPC1 (0.50) NPC1RAB9AMAPK1ALOX15NQO2
SCHEMBL200838 0.73 NPC1 (0.50) NPC1RAB9AMAPK1ALOX15NQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150239878-A1 Novel Compounds for Imaging Tau Proteins That Accumulate In Brain NATIONAL INSTITUTES FOR QUANTUM AND RADIOLOGICAL SCIENCE AND TECHNOLOGY (JP) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150239878-A1 Novel Compounds for Imaging Tau Proteins That Accumulate In Brain MAPT, FABP7, HTT NPC1 1994/4885RAB9A 1040/4885GAA 4201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.